Mizuho cuts BioXcel to neutral, cites reduced expectations for lead drug (BTAI) Markets August 16, 2023 juststock Mizuho downgraded BioXcel Therapeutics (NASDAQ:BTAI) to impartial and slashed its worth goal within the wake of the corporate’s Q2…
